Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia

Möglichkeiten register-basierter Studien zur Erforschung seltener Erkrankungen

(2012) G. Nagel et al.   AKTUELLE NEUROLOGIE

Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample

(2012) Z. S. Nasreddine et al.   NEUROLOGY

Amyotrophic lateral sclerosis

(2011) Matthew C Kiernan et al.   LANCET

Urgently needed—biomarkers for amyotrophic lateral sclerosis

(2011) Albert C. Ludolph   Nature Reviews Neurology

Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB)

(2010) Yaffa R. Rubinstein et al.   Contemporary Clinical Trials

The case for a global rare-diseases registry

(2010) Christopher B Forrest et al.   LANCET

Smoking and risk for amyotrophic lateral sclerosis: Analysis of the EPIC cohort

(2009) Valentina Gallo et al.   ANNALS OF NEUROLOGY

Translation of rare disease research into orphan drug development: disease matters

(2009) Harald E. Heemstra et al.   DRUG DISCOVERY TODAY

Incidence of amyotrophic lateral sclerosis in Europe

(2009) G. Logroscino et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Categorizing the world of registries

(2008) Brian C. Drolet et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Why rare diseases are an important medical and social issue

(2008) Arrigo Schieppati et al.   LANCET